Impact of comorbidities on perioperative outcomes for carcinoma of oral cavity

被引:13
作者
Katna, R. [1 ,2 ]
Kalyani, N. [1 ]
Agarwal, S. [2 ]
Singh, S. [1 ,2 ]
Deshpande, A. [1 ,2 ]
Bhosale, B. [1 ,2 ]
机构
[1] Jaslok Hosp & Res Ctr, Mumbai, Maharashtra, India
[2] Bombay Hosp & Res Ctr, Mumbai, Maharashtra, India
关键词
Charlson Comorbidity Index; Washington University Head and Neck Comorbidity Index; Comorbidities; Oral cancers; CO-MORBIDITY; NECK-CANCER; HEAD; INDEX; VALIDATION; MORTALITY;
D O I
10.1308/rcsann.2019.0155
中图分类号
R61 [外科手术学];
学科分类号
摘要
INTRODUCTION Surgical management of oral cavity carcinoma involves composite resection with reconstruction. Comorbidities increase the risk of perioperative complications. Objective stratification is important for uneventful recovery. The Charlson Comorbidity Index and the Washington University Head and Neck Comorbidity Index were used to assess perioperative morbidity and mortality. MATERIALS AND METHODS This was a prospective study of 531 patients with head and neck squamous cell carcinoma who were treated between January 2014 and December 2017. Patients' comorbidity scores on the Charlson Comorbidity Index and Washington University Head and Neck Comorbidity Index were recorded. RESULTS The median age of the cohort was 49 years. Median Charlson Comorbidity Index score was 3 and Washington University Head and Neck Comorbidity Index was 0. There were five mortalities with a Charlson Comorbidity Index score of 4 or more. Fifteen patients had either infection, leak or postoperative bleeding. A Charlson Comorbidity Index of 4 or more was associated with higher event rate and poor overall survival (p=0.001) CONCLUSION Higher Charlson Comorbidity Index score is associated with increased incidence of peri-operative morbidity and mortality, while the Washington University Head and Neck Comorbidity Index is a poor predictor of the same.
引用
收藏
页码:232 / 235
页数:4
相关论文
共 14 条
[1]  
[Anonymous], 2016, TRANSLATIONAL RES OR
[2]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[3]   Comorbidity as a major risk factor for mortality and complications in head and neck surgery [J].
Ferrier, MB ;
Spuesens, EB ;
Le Cessie, S ;
De Jong, RJB .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (01) :27-32
[4]   Surgical morbidity and mortality in patients after microvascular reconstruction for head and neck cancer [J].
Joo, Y-H. ;
Cho, K-J. ;
Park, J-O. ;
Kim, S-Y. ;
Kim, M-S. .
CLINICAL OTOLARYNGOLOGY, 2018, 43 (02) :502-508
[5]   IMPORTANCE OF CLASSIFYING INITIAL CO-MORBIDITY IN EVALUATING OUTCOME OF DIABETES-MELLITUS [J].
KAPLAN, MH ;
FEINSTEIN, AR .
JOURNAL OF CHRONIC DISEASES, 1974, 27 (7-8) :387-404
[6]   Development of a comorbidity index using physician claims data [J].
Klabunde, CN ;
Potosky, AL ;
Legler, JM ;
Warren, JL .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (12) :1258-1267
[7]   Tobacco, Alcohol, and Cancer in Low and High Income Countries [J].
Lee, Yuan-Chin Amy ;
Hashibe, Mia .
ANNALS OF GLOBAL HEALTH, 2014, 80 (05) :378-383
[8]   Head and neck free-flap reconstruction in the elderly [J].
Nao, E. E. M. ;
Dassonville, O. ;
Chamorey, E. ;
Poissonnet, G. ;
Pierre, C. -S. ;
Riss, J. -C. ;
Agopian, B. ;
Peyrade, F. ;
Benezery, K. ;
Hechema, R. ;
Sudaka, A. ;
Vallicioni, J. ;
Demard, F. ;
Santini, J. ;
Bozec, A. .
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2011, 128 (02) :47-51
[9]   Importance of comorbidity in head and neck cancer [J].
Piccirillo, JF .
LARYNGOSCOPE, 2000, 110 (04) :593-602
[10]   Development of a new head and neck cancer-specific comorbidity index [J].
Piccirillo, JF ;
Lacy, PD ;
Basu, A ;
Spitznagel, EL .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (10) :1172-1179